stockportfolio.pro
IDEXX Laboratories, Inc. P/E Ratio 2008–2025
IDEXX Laboratories, Inc. (IDXX) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +6.0%/yr over 17 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 51.72 | +33.5% |
| FY 2024 | 38.75 | -29.8% |
| FY 2023 | 55.17 | +8.6% |
| FY 2022 | 50.80 | -33.6% |
| FY 2021 | 76.57 | +2.8% |
| FY 2020 | 74.50 | +39.5% |
| FY 2019 | 53.40 | +22.3% |
| FY 2018 | 43.67 | -17.9% |
| FY 2017 | 53.19 | +10.7% |
| FY 2016 | 48.06 | +35.1% |
| FY 2015 | 35.57 | -14.1% |
| FY 2014 | 41.42 | +35.5% |
| FY 2013 | 30.57 | +4.4% |
| FY 2012 | 29.27 | +5.7% |
| FY 2011 | 27.68 | -5.2% |
| FY 2010 | 29.21 | +9.8% |
| FY 2009 | 26.59 | +37.8% |
| FY 2008 | 19.29 | — |
Source: IDEXX Laboratories, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for IDEXX Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIDEXX Laboratories, Inc. — frequently asked questions
What is IDEXX Laboratories, Inc.'s price-to-earnings ratio?
IDEXX Laboratories, Inc. (IDXX) reported price-to-earnings ratio of 51.72 for fiscal year 2025, per its SEC filings.
How has IDEXX Laboratories, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, IDXX's price-to-earnings ratio grew at roughly 6.0% per year (compound annual rate), from 19.29 to 51.72.
Where does this data come from?
Figures are computed from IDEXX Laboratories, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.